Dengke Pan, People's Republic of China

Dengke Pan Ph.D. Professor
Deputy director of Xenotransplantation Group of Organ Transplantation Branch of Chinese Medical Association.
CEO, Chengdu ClonOrgan Biotechnology Co. Ltd, Chengdu, China
I have been engaged in the research of gene modified pigs for more than 20 years, established several Chinese unprecedented records. I bred the first cloned pig, the first αGalKO pig and has bred more than 10 kinds of gene editing donor pig strains. The conservation breeding and stable passage of the multiple gene modified donor pig are realized. A medical ultra-clean DPF facility has been built to provide clinical biosafety organ donor pigs. It has cooperated with medical institutions to carry out more than 70 pre-clinical trials of gene editing pig liver, kidney, heart to non-human primates. We completed the world's first subclinical study on the transplantation of gene-edited pig liver, lung and red blood cells into brain-dead patients, the fifth cases in the world and the first clinical study of gene-edited pig kidney to a living patient in China.